Intrahepatic cholestasis of pregnancy, first trimester
ICD-10 O26.641 is a billable code used to indicate a diagnosis of intrahepatic cholestasis of pregnancy, first trimester.
Intrahepatic cholestasis of pregnancy (ICP) is a liver disorder that occurs during pregnancy, characterized by intense itching and elevated bile acids in the bloodstream. It typically manifests in the second or third trimester but can occur as early as the first trimester. The condition is thought to be related to hormonal changes and genetic predisposition, leading to impaired bile flow. Symptoms include pruritus, particularly on the palms and soles, and may be accompanied by jaundice in more severe cases. ICP poses risks to both the mother and fetus, including preterm birth and fetal distress due to bile acid toxicity. Management often involves monitoring liver function tests, bile acid levels, and fetal well-being, with treatment options including ursodeoxycholic acid to alleviate symptoms and reduce bile acid levels. Close collaboration among obstetricians, maternal-fetal medicine specialists, and hepatologists is essential for optimal maternal and fetal outcomes.
Detailed documentation of symptoms, lab results, and treatment plans is essential. Include any consultations with specialists.
A pregnant patient presents with severe itching and elevated liver enzymes; management and monitoring protocols are initiated.
Ensure that all symptoms are documented clearly, and any changes in treatment are noted to support coding.
High-risk pregnancy documentation must include comprehensive assessments of both maternal and fetal health, including ultrasound findings and fetal monitoring.
A patient with ICP is monitored for fetal distress due to elevated bile acids; interventions are documented.
Focus on the potential impact of ICP on fetal outcomes and ensure that all relevant data is captured.
Used for follow-up visits in patients diagnosed with ICP.
Document the patient's symptoms, lab results, and treatment plan.
Ensure that the visit is clearly linked to the management of ICP.
Common symptoms include intense itching, particularly on the palms and soles, and in some cases, jaundice. These symptoms can significantly impact the quality of life during pregnancy.
